Pharmacogenomics and the (ir)relevance of race

Pharmacogenomics Journal

Volumn 1, Issue 2, 2001, Pages 104-108

  Rothstein, M A ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ETHNIC GROUP; GENETICS; HEALTH STATUS; HUMAN; PHARMACOGENETICS; PHARMACOLOGY; RACE; RESEARCH;

CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; HEALTH STATUS; HUMANS; PHARMACOGENETICS; PHARMACOLOGY; RESEARCH;

EID: 0035750203     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500029     Document Type: Article

References (5)

1. Reference deleted in proof.
2. RS Schwartz. Racial profiling in medical research. N Eng / Med 2001; 344: 1392-1393.
3. J Gu et al. Ethnic differences in poly CADP-ribose polymerase pseudogene genotype distribution association with lung cancer risk. Cardnogenesis 1999; 20: 1465-1469.
4. CM Stein et al. Hypertension in black people: study of specific genotypes and phenotypes will provide a greater understanding of interindividual and interethnic variability in blood pressure regulation than studies based on race. Pharmacogenetics 2001; 11: 95-110.
5. S Olson. Genetic archaeology of race. All Monthly 2001; 287: 69-80.